Lee Pharmaceuticals v. Juanita M. Kreps, Secretary of Commerce

577 F.2d 610, 198 U.S.P.Q. (BNA) 601, 1978 U.S. App. LEXIS 10453
CourtCourt of Appeals for the Ninth Circuit
DecidedJune 29, 1978
Docket76-2082
StatusPublished

This text of 577 F.2d 610 (Lee Pharmaceuticals v. Juanita M. Kreps, Secretary of Commerce) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lee Pharmaceuticals v. Juanita M. Kreps, Secretary of Commerce, 577 F.2d 610, 198 U.S.P.Q. (BNA) 601, 1978 U.S. App. LEXIS 10453 (9th Cir. 1978).

Opinion

577 F.2d 610

198 U.S.P.Q. 601

LEE PHARMACEUTICALS, Plaintiff-Appellant,
v.
Juanita M. KREPS, Secretary of Commerce, et al., Defendants-Appellees.

No. 76-2082.

United States Court of Appeals,
Ninth Circuit.

June 29, 1978.

Mary Helen Sears (argued), of Irons & Sears, Washington, D. C., for plaintiff-appellant.

Alice Mattice (argued), Washington, D. C., for defendants-appellees.

Appeal from the United States District Court for the Central District of California.

Before HUFSTEDLER and WRIGHT, Circuit Judges, and SOLOMON,* District Judge.

HUFSTEDLER, Circuit Judge:

Lee Pharmaceuticals ("Lee"), a patent applicant, brought this action to compel the Patent Office to produce abandoned patent applications under the Freedom of Information Act ("FOIA"), 5 U.S.C. § 552 (1977) and to consider such applications as evidence of prior art in evaluating Lee's claims of patentability, under 35 U.S.C. § 131 (1970). Lee appeals from a judgment dismissing its complaint for failure to state a claim upon which relief could be granted. We affirm, holding that (1) abandoned patent applications are not producible under FOIA because section 122 of the Patent Act (35 U.S.C. § 122 (1970) ("(a)pplications for patents shall be kept in confidence by the Patent Office")) is a specific statutory exemption from disclosure within the meaning of Exemption 3 of FOIA (5 U.S.C. § 552(b)(3) (as amended in 1976)), and (2) no justiciable controversy is presented by Lee's challenge to Patent Office procedures.

Lee applied for a patent for a "carvable, dental composite restorative material" (Serial No. 504,838). Before the Patent Office began examining its application, Lee wrote to the Solicitor of the Patent Office demanding that abandoned patent applications for products similar to its own be considered as evidence of prior art in the examination process and demanding that copies of those applications be made available to Lee under FOIA. The Solicitor and later the Commissioner of Patents refused the demand relying upon 35 U.S.C. § 122 and citing Sears v. Gottschalk (4th Cir. 1974) 502 F.2d 122, cert. denied sub nom. Sears v. Dann (1975) 422 U.S. 1056, 95 S.Ct. 2680, 45 L.Ed.2d 709.1 The Commissioner also told Lee that it had no obligation under FOIA to conduct any examination of its patent applications as requested. Lee then brought this action.

Lee's contentions must be placed in the context of the statutes and regulations generally applicable to patent applicants. The Patent Office was created to implement the federal government's constitutional duty to secure to "Inventors the exclusive Right to their respective . . . Discoveries." (United States Constitution, Art. 1, § 8, Cl. 8. See Kewanee Oil Co. v. Bicron Corp. (1974) 416 U.S. 470, 480-83, 94 S.Ct. 1879, 40 L.Ed.2d 315.) The earliest legislation conferring jurisdiction to grant patents was enacted in 1790 and following numerous intervening enactments, the law was clarified and codified by the Patent Act of 1952. (See P. J. Federico, Commentary on the New Patent Act, in 35 U.S.C.A. § 1 at pp. 2-10.) Congress has invested the Commissioner of Patents with broad discretion to establish procedures for the granting and issuing of patents (35 U.S.C. § 6), which has resulted in the issuance of detailed administrative regulations. (See 37 C.F.R. §§ 1.1 et seq. (1977).) Patent applicants whose claims are rejected may obtain internal re-examination and reconsideration by the Patent Office (id. § 1.111-.113) and appeal the rejection of a claim of patentability to the Board of Patent Appeals. (35 U.S.C. § 134; 37 C.F.R. §§ 1.191-.198.) Judicial review of the Board's determination is available alternatively in the Court of Customs and Patent Appeals (35 U.S.C. § 141-44; 37 C.F.R. §§ 1.301-.302) or "by civil action against the Commissioner in the United States District Court for the District of Columbia." (35 U.S.C. § 145; 37 C.F.R. §§ 1.303-.304.)

The principal provision of the Patent Act respecting the duty to examine patent applications is 35 U.S.C. § 131 which provides: "The Commissioner shall cause an examination to be made of the application and the alleged new invention; and if on such examination it appears that the applicant is entitled to a patent under the law, the Commissioner shall issue a patent therefor." Of critical import to patentability is the question whether the "invention" is truly novel (see 35 U.S.C. §§ 101 ("Whoever invents or discovers any new and useful process . . . or any new and useful improvement thereof, may obtain a patent . . . .") & 102 (conditions of patentability exclude, inter alia, inventions "known or used by others in this country")). Thus, 35 U.S.C. § 103 provides in pertinent part that a "patent may not be obtained . . . if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art as to which said subject matter pertains." Patent examiners must by regulation "make a thorough study (of the application) and shall make a thorough investigation of the available prior art relating to the subject matter of the invention sought to be patented." (37 C.F.R. § 1.104(a).) The relevancy of prior art to a patent examination proceeding is described in 5 Deller's Walker on Patents § 453, at 361 (2d ed. 1972) as anything in tangible form that may properly be relied upon "in support of a rejection on a matter of substance, not form, of a claim in a pending application for patent."

Although abandoned patent applications were used as evidence of prior art very early in the history of the United States Patent Office, the practice has been discontinued since at least 1879. (Alexander Milburn Co. v. Davis-Bouronville Co. (1926) 270 U.S. 390, 400, 402, 46 S.Ct. 324, 325, 70 L.Ed. 651 (the practice "is convenient if not necessary to the Patent Office, and we are not disposed to disturb it").) Abandoned patent applications are not used because the secrecy of patent applications negates any assumption that their contents "would have been obvious" to the relevant segment of the public. (35 U.S.C. § 122; 37 C.F.R. § 1.14(a) & (b); Sears v. Gottschalk, supra, 502 F.2d at 131-32. See The Corn-Planter Patent (1874)90 U.S. (23 Wall.) 181, 210-11, 23 L.Ed. 161 (abandoned patent applications do not necessarily evidence prior use of invention and therefore do not bar patentability of later similar device). See also Application of Lund (1967)376 F.2d 982

Free access — add to your briefcase to read the full text and ask questions with AI

Related

The Corn-Planter Patent
90 U.S. 181 (Supreme Court, 1874)
Alexander Milburn Co. v. Davis-Bournonville Co.
270 U.S. 390 (Supreme Court, 1926)
Aetna Life Insurance v. Haworth
300 U.S. 227 (Supreme Court, 1937)
Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
Gardner v. Toilet Goods Assn., Inc.
387 U.S. 167 (Supreme Court, 1967)
Flast v. Cohen
392 U.S. 83 (Supreme Court, 1968)
Lear, Inc. v. Adkins
395 U.S. 653 (Supreme Court, 1969)
Environmental Protection Agency v. Mink
410 U.S. 73 (Supreme Court, 1973)
Sampson v. Murray
415 U.S. 61 (Supreme Court, 1974)
Kewanee Oil Co. v. Bicron Corp.
416 U.S. 470 (Supreme Court, 1974)
Bradley v. School Bd. of Richmond
416 U.S. 696 (Supreme Court, 1974)
Department of the Air Force v. Rose
425 U.S. 352 (Supreme Court, 1976)
Califano v. Sanders
430 U.S. 99 (Supreme Court, 1977)
Application of Frantz Lund and Wagn Ole Godtfredsen
376 F.2d 982 (Customs and Patent Appeals, 1967)
Ernestine Robles v. Environmental Protection Agency
484 F.2d 843 (Fourth Circuit, 1973)

Cite This Page — Counsel Stack

Bluebook (online)
577 F.2d 610, 198 U.S.P.Q. (BNA) 601, 1978 U.S. App. LEXIS 10453, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lee-pharmaceuticals-v-juanita-m-kreps-secretary-of-commerce-ca9-1978.